+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Non-invasive Prenatal Testing Global Market Report 2024

  • PDF Icon

    Report

  • 175 Pages
  • November 2023
  • Region: Global
  • The Business Research Company
  • ID: 5735463

Quick Summary:

The rapidly evolving non-invasive prenatal testing market is driving immense interests from senior executives seeking to capitalize on its promising growth and stay ahead of industry trends. The prevalence of genetic disorders, increasing maternal age, and significant advancements in prenatal screening technologies are key growth catalysts poised to transform this market.

This comprehensive market research report will furnish you with critical insights into the competitive landscape, regional analysis, market segmentation, and key players. Gain an understanding of the impact of trends and regulatory changes on the future market expansion. Examine the types of testing methodologies, their applications, and the ethical issues shaping this industry. This report is an essential tool for enlightening your strategic decision-making, harnessing opportunities, and navigating the challenges in the non-invasive prenatal testing industry.

The non-invasive prenatal testing market size has grown rapidly in recent years. It will grow from $4.73 billion in 2023 to $5.44 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The growth observed during the historical period can be attributed to factors such as enhanced accuracy, decreased risk, the trend of increasing maternal age, heightened awareness, and the influence of clinical guidelines.

The non-invasive prenatal testing market size is expected to see rapid growth in the next few years. It will grow to $9.43 billion in 2028 at a compound annual growth rate (CAGR) of 14.7%. The anticipated growth in the forecast period can be linked to the expansion of test offerings, increased accessibility, a rising trend in maternal age, the enhanced detection of fetal anomalies, and the influence of telemedicine and digital health. Prominent trends in this forecast period include the broadening of test panels, the widespread adoption of non-invasive prenatal testing (NIPT), technological advancements, and the development of non-invasive fetal aneuploidy diagnosis (NIFAD).

The high incidence rate of Down syndrome is a significant factor propelling the growth of the non-invasive prenatal testing (NIPT) market, especially with the increasing trend of older maternal age, which raises concerns about fetal well-being. Down syndrome, a chromosomal condition resulting from an error in cell division, leads to an extra chromosome 21 and can impact the cognitive and physical development of the fetus. NIPT screening tests offer a safe and non-invasive means of detecting Down syndrome, posing no harm to the mother or baby and carrying no risk of miscarriage. These tests can identify over 99% of Down syndrome cases. In the USA, the National Down Syndrome Society and the Centers for Disease Control and Prevention report that 1 in every 700 babies is born with Down syndrome, and 80% of children with Down syndrome are born to older mothers. The increased risk associated with advanced maternal age is a driving force behind the growth of the NIPT market.

The key categories of non-invasive prenatal testing encompass consumables and instruments. Consumables refer to products that are used and depleted during their application. Instruments include NGS systems, PCR instruments, microarrays, ultrasound devices, and other equipment like centrifuges, UV systems, incubators, and microscopes. Various consumables comprise assay kits and reagents, as well as disposables. These applications pertain to the detection of conditions such as trisomy, microdeletion, genetics, and the Rh factor, and are typically employed by hospitals and diagnostic laboratories.

The non-invasive prenatal testing market research report is one of a series of new reports that provides non-invasive prenatal testing market statistics, including non-invasive prenatal testing industry global market size, regional shares, competitors with a non-invasive prenatal testing market share, detailed non-invasive prenatal testing market segments, market trends and opportunities, and any further data you may need to thrive in the non-invasive prenatal testing industry. This non-invasive prenatal testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The increasing maternal age is expected to be a key driver of the non-invasive prenatal testing market's expansion in the foreseeable future. Factors such as pursuing education, career opportunities, financial stability, personal choices, delayed marriage, improved contraception, and societal changes have led to women delaying childbirth. This delay increases the risk of chromosomal abnormalities, prompting more expectant mothers to opt for NIPT to assess their pregnancy's health. For example, data from the Centers for Disease Control and Prevention in June 2023 indicates a 2% increase in the provisional birth rate for women aged 35-39 from 2021 to 2022, with a 2% rise in the number of births to women in their late 30s. Additionally, the provisional birth rate for women aged 40-44 increased by 4% from 2021 to 2022, with a 6% rise in the number of births to these women. The provisional birth rate for women aged 45-49 (including those aged 50 and older) increased by 1.1 births per 1,000 women in 2022, up from 0.9 in 2021, marking the first change in this rate since 2015 and a 12% increase in the number of births to women in this age group. Therefore, increasing maternal age will continue to drive the growth of the non-invasive prenatal testing market.

The non-invasive prenatal testing (NIPT) market faces ethical challenges, particularly concerning issues related to sex selection and the abortion of fetuses with chromosomal abnormalities. Determining the sex of the fetus or identifying abnormalities at an early stage has raised ethical concerns, leading to stricter regulations on the use of such diagnostic tools. In the UK, a record 214,869 abortions were performed in England and Wales in 2021, the highest number since abortion became legal in 1967. These ethical dilemmas can pose constraints on the non-invasive prenatal testing market.

The integration of next-generation sequencing technology has significantly enhanced the capabilities of researchers, enabling them to conduct a wide range of applications and study biological systems at a higher level. Next-generation sequencing allows for the simultaneous sequencing of thousands to millions of DNA molecules, reducing both time and cost while optimizing results for genome and DNA testing. Major companies like Illumina, Eurofins, Natera, Roche, and Annoroad have adopted this technology for non-invasive prenatal testing. The China Food and Drug Administration (CFDA) has approved the medical instrument product registration for Annoroad's NGS instrument NextSeq 550AR.

The non-invasive prenatal testing market is subject to strict regulation by various international and country-specific agencies. For instance, the US Food and Drug Administration (FDA) issues certifications for Laboratory Developed Tests (LDTs) and Clinical Laboratory Improvement Amendments (CLIA). Manufacturers must obtain a 510(k) premarket notification for in vitro diagnostic tests, with LDTs and CLIA certification based on the number of tests conducted during clinical trials. For instance, for trisomy 21 (Down syndrome), with an incidence rate of 1/1000, at least 100,000 samples would need to be tested to meet the requirements of a 510(k). A 510(k) premarket notification ensures that the new product is as safe and effective as other legally-marketed devices, and manufacturers must register such notifications before commercially marketing new products.

In May 2021, Echelon Diagnostics, a US-based leader in genomic healthcare AI imaging analysis and big data solutions, signed a collaboration agreement with Cradle Genomics for an undisclosed amount. This partnership aims to accelerate the development of Cradle's cellular-based non-invasive prenatal diagnostic (NIPD) products. Cradle Genomics, a US-based company specializing in non-invasive prenatal testing services, offers diagnostic solutions.

Major companies operating in the non-invasive prenatal testing market include F. Hoffmann-La Roche AG, Illumina Inc., Laboratory Corporation of America Holdings, Natera Inc., PerkinElmer Inc., Quest Diagnostics Inc., Agilent Technologies Inc., BGI Diagnosis Co Ltd., Berry Genomics Co, LifeCodexx AG, Myriad Genetics Inc., NIPD Genetics Co Ltd., Sequenom Inc., Annoroad Gene Technology Co Ltd., Centogene AG, Counsyl Inc., EUROFINS Genoma Group, Eurofins Scientific SE, Next Biosciences, Premaitha Health PLC, Ariosa Diagnostics Inc., Beijing Genomics Institute, Yourgene Health PLC, GE Healthcare Technologies Inc., Koninklijke Philips NV, Thermo Fisher Scientific Inc., Pacific Biosciences of California Inc., QIAGEN NV, MedGenome Labs Ltd., Progenity Inc.

North America was the largest region in the non-invasive prenatal testing market in 2023. Western Europe was the second largest region in the non-invasive prenatal testing market. The regions covered in the non-invasive prenatal testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the non-invasive prenatal testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The non-invasive prenatal testing market includes revenue earned by ultrasound detection, fetal cells in maternal blood tests, cell-free DNA in maternal plasma tests, and biochemical screening tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Non-invasive Prenatal Testing Market Characteristics3. Non-invasive Prenatal Testing Market Trends And Strategies
4. Non-invasive Prenatal Testing Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Non-invasive Prenatal Testing Market Size and Growth
5.1. Global Non-invasive Prenatal Testing Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Non-invasive Prenatal Testing Historic Market Size and Growth, 2018 2023, Value ($ Billion)
5.3. Global Non-invasive Prenatal Testing Forecast Market Size and Growth, 2023 2028, 2033F, Value ($ Billion)
6. Non-invasive Prenatal Testing Market Segmentation
6.1. Global Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Consumables
  • Instruments
6.2. Global Non-invasive Prenatal Testing Market, Segmentation By Instruments, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • NGS Systems
  • Polymerase Chain Reaction (PCR) Instruments
  • Microarrays
  • Ultrasound Devices
  • Others(Centrifuges
6.3. Global Non-invasive Prenatal Testing Market, Segmentation By Consumables, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Assay Kits And Reagents
  • Disposables
6.4. Global Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Trisomy
  • Microdeletion
  • Genetics
  • Rh factor
6.5. Global Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital
  • Diagnostic Labs
7. Non-invasive Prenatal Testing Market Regional And Country Analysis
7.1. Global Non-invasive Prenatal Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Non-invasive Prenatal Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Non-invasive Prenatal Testing Market
8.1. Asia-Pacific Non-invasive Prenatal Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Non-invasive Prenatal Testing Market
9.1. China Non-invasive Prenatal Testing Market Overview
9.2. China Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Non-invasive Prenatal Testing Market
10.1. India Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Non-invasive Prenatal Testing Market
11.1. Japan Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.2. Japan Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Non-invasive Prenatal Testing Market
12.1. Australia Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Non-invasive Prenatal Testing Market
13.1. Indonesia Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Non-invasive Prenatal Testing Market
14.1. South Korea Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.2. South Korea Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Non-invasive Prenatal Testing Market
15.1. Western Europe Non-invasive Prenatal Testing Market Overview
15.2. Western Europe Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Non-invasive Prenatal Testing Market
16.1. UK Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Non-invasive Prenatal Testing Market
17.1. Germany Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Non-invasive Prenatal Testing Market
18.5. France Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Non-invasive Prenatal Testing Market
19.9. Italy Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Non-invasive Prenatal Testing Market
20.13. Spain Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Non-invasive Prenatal Testing Market
21.1. Eastern Europe Non-invasive Prenatal Testing Market Overview
21.2. Eastern Europe Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Non-invasive Prenatal Testing Market
22.1. Russia Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Non-invasive Prenatal Testing Market
23.1. North America Non-invasive Prenatal Testing Market Overview
23.2. North America Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Non-invasive Prenatal Testing Market
24.1. USA Non-invasive Prenatal Testing Market Overview
24.2. USA Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Non-invasive Prenatal Testing Market
25.1. Canada Non-invasive Prenatal Testing Market Overview
25.2. Canada Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Non-invasive Prenatal Testing Market
26.1. South America Non-invasive Prenatal Testing Market Overview
26.2. South America Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Non-invasive Prenatal Testing Market
27.1. Brazil Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Non-invasive Prenatal Testing Market
28.1. Middle East Non-invasive Prenatal Testing Market Overview
28.2. Middle East Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Non-invasive Prenatal Testing Market
29.1. Africa Non-invasive Prenatal Testing Market Overview
29.2. Africa Non-invasive Prenatal Testing Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Non-invasive Prenatal Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Non-invasive Prenatal Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Non-invasive Prenatal Testing Market Competitive Landscape And Company Profiles
30.1. Non-invasive Prenatal Testing Market Competitive Landscape
30.2. Non-invasive Prenatal Testing Market Company Profiles
30.2.1. F. Hoffmann-La Roche AG
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Illumina Inc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Laboratory Corporation of America Holdings
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Natera Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. PerkinElmer Inc
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Global Non-invasive Prenatal Testing Market Competitive Benchmarking32. Global Non-invasive Prenatal Testing Market Competitive Dashboard33. Key Mergers And Acquisitions In The Non-invasive Prenatal Testing Market
34. Non-invasive Prenatal Testing Market Future Outlook and Potential Analysis
34.1 Non-invasive Prenatal Testing Market In 2028 - Countries Offering Most New Opportunities
34.2 Non-invasive Prenatal Testing Market In 2028 - Segments Offering Most New Opportunities
34.3 Non-invasive Prenatal Testing Market In 2028 - Growth Strategies
34.3.1 Market Trend Based Strategies
34.3.2 Competitor Strategies
35. Appendix
35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer

Executive Summary

Non-invasive Prenatal Testing Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on non-invasive prenatal testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for non-invasive prenatal testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

  • Markets Covered: 1) By Type: Consumables; Instruments; 2) By Application: Trisomy; Microdeletion; Genetics; Rh factor; 3) By End User: Hospital; Diagnostic Labs
  • Subsegment: NGS Systems; PCR Instruments; Microarrays; Ultrasound Devices; Others(Centrifuges; UV Systems; Incubators; Microscopes); Assay Kits &Reagents; Disposables
  • Companies Mentioned: F. Hoffmann-La Roche AG; Illumina Inc.; Laboratory Corporation of America Holdings; Natera Inc.; PerkinElmer Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • F. Hoffmann-La Roche AG
  • Illumina Inc.
  • Laboratory Corporation of America Holdings
  • Natera Inc.
  • PerkinElmer Inc.
  • Quest Diagnostics Inc.
  • Agilent Technologies Inc.
  • BGI Diagnosis Co Ltd.
  • Berry Genomics Co
  • LifeCodexx AG
  • Myriad Genetics Inc.
  • NIPD Genetics Co Ltd.
  • Sequenom Inc.
  • Annoroad Gene Technology Co Ltd.
  • Centogene AG
  • Counsyl Inc.
  • EUROFINS Genoma Group
  • Eurofins Scientific SE
  • Next Biosciences
  • Premaitha Health Plc
  • Ariosa Diagnostics Inc.
  • Beijing Genomics Institute
  • Yourgene Health PLC
  • GE Healthcare Technologies Inc.
  • Koninklijke Philips NV
  • Thermo Fisher Scientific Inc.
  • Pacific Biosciences of California Inc.
  • QIAGEN NV
  • MedGenome Labs Ltd.
  • Progenity Inc.

Methodology

Loading
LOADING...